Published in J Gen Virol on August 01, 2001
Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog (2006) 10.08
Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element. J Virol (2008) 0.80
Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract (1990) 1.75
Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J Virol (1989) 1.25
Human orf. J Cutan Pathol (1975) 1.03
Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer (2007) 1.00
Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care (1989) 0.99
Anogenital human papillomavirus in non-abused preschool children. Acta Paediatr (2003) 0.94
The effect of acidic polysaccharides and prostaglandin-like substances isolated from Propionibacterium acnes on granulocyte chemotaxis. Experientia (1979) 0.92
Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir (Wien) (1992) 0.91
Induced abortion: Chlamydia trachomatis and postabortal complications. A cost benefit analysis. Acta Obstet Gynecol Scand (1988) 0.90
Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother (1991) 0.88
[Chlamydia trachomatis in cervix uteri specimens among patients in general practice]. Tidsskr Nor Laegeforen (1988) 0.88
Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study. J Exp Clin Cancer Res (2007) 0.88
Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris. Arch Dermatol Res (1980) 0.85
Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res (1992) 0.84
Papillomatosis of the esophagus. J Clin Gastroenterol (1996) 0.84
[Chlamydia trachomatis. Screening of pregnant women]. Tidsskr Nor Laegeforen (1987) 0.84
Expression of epidermal growth factor receptor in human meningiomas and meningeal tissue. APMIS (1992) 0.82
Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2. J Virol (1994) 0.82
The prevalence of Chlamydia trachomatis in the cervix of puerperal women, and its consequences for the outcome of pregnancy. Scand J Prim Health Care (1986) 0.81
Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats. J Virol (1991) 0.81
C-erbB-2/HER-2 protein in human intracranial tumours. Eur J Cancer (1993) 0.80
Three sisters with Addison's disease. J Clin Endocrinol Metab (1998) 0.80
Multiple derangements of cytokine homeostasis in mice infected with immunosuppressive retrovirus. Cell Immunol (1993) 0.80
Detection of cytomegalovirus using 'boosted' nested PCR. Mol Cell Probes (1995) 0.80
Immunohistochemical detection of epidermal growth factor receptor in human high-grade astrocytomas--a comparison between frozen- and paraffin sections. J Exp Clin Cancer Res (2005) 0.80
The murine leukemia virus LTR in oncogenesis: effect of point mutations and chromosomal integration sites. Radiat Environ Biophys (1991) 0.80
Expression of the epidermal growth factor receptor gene in human brain metastases. APMIS (1992) 0.78
Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours. Br J Neurosurg (1988) 0.78
Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors. Cancer Immunol Immunother (1988) 0.78
Cytotoxicity studies on some novel 2,6-dimethoxyhydroquinone derivatives. Anticancer Drug Des (1992) 0.77
Acute hemolytic anemia related to diphtheria-pertussis-tetanus vaccination. Acta Paediatr Scand (1978) 0.77
A low oncogenic variant of Friend murine leukemia virus with strong immunosuppressive properties. Arch Virol (1993) 0.77
Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable? J Eur Acad Dermatol Venereol (2006) 0.76
Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2. J Virol (1998) 0.76
Chlamydia trachomatis: is it possible to reduce the number of infections after abortions? Scand J Prim Health Care (1988) 0.76
Epidermal growth-factor and transforming growth factor-alpha in human meningiomas. Int J Oncol (1993) 0.76
Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line. J Neurooncol (1988) 0.75
An immunosuppressive murine leukaemia virus induces a Th1-->Th2 switch and abrogates the IgM antibody response to sheep erythrocytes by suppressing the production of IL-2. Clin Exp Immunol (1995) 0.75
The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line. J Neurooncol (1988) 0.75
A human IgA myeloma protein interacting with staphylococcal alpha-toxin and protein A. Clin Exp Immunol (1977) 0.75
[Chlamydia trachomatis in induced abortion]. Tidsskr Nor Laegeforen (1987) 0.75
A new technique to register proliferation of clonogenic cells from brain tumors. J Neurooncol (1985) 0.75
An isotope agarose assay for rapid testing of the sensitivity of glioma biopsies to chemotherapeutic drugs and biological response modifiers. Effects of BCNU, vincristine, lymphokines and the recombinant agents interferon alpha 2c, interferon gamma and tumour necrosis factor. Acta Neurochir (Wien) (1988) 0.75
Effects of interferon-gamma and tumor necrosis factor-alpha on clonogenic growth of cell lines and primary cultures from human gliomas and brain metastases. APMIS (1989) 0.75
[Chlamydia trachomatis and ectopic pregnancy. A causal relationship]. Tidsskr Nor Laegeforen (1989) 0.75
The effect of type beta transforming growth factor on proliferation of clonogenic cells from human gliomas. Acta Neurochir Suppl (Wien) (1988) 0.75
Genital Chlamydia trachomatis infections in patients with abnormal cervical smears: effect of tetracycline treatment on cell changes. Obstet Gynecol (1989) 0.75
Synthesis and cytotoxicity studies of novel cyclic peptide-2,6-dimethoxyhydroquinone-3-mercaptoacetic acid conjugates. Anticancer Drug Des (1993) 0.75
The presence in faecal extracts of bacterial cell wall components resembling viral structures. Acta Pathol Microbiol Scand B (1978) 0.75
[Encephalitis after acute Epstein-Barr virus infection]. Tidsskr Nor Laegeforen (2001) 0.75
A comparative neonatal study of infants born by mothers with Chlamydia trachomatis in cervix uteri. Acta Paediatr Scand (1987) 0.75
[Chlamydia trachomatis and infertility in women]. Tidsskr Nor Laegeforen (1989) 0.75
EGF-effects in vitro and in vivo on a carcinoma cell line rich in EGFR. Anticancer Res (1995) 0.75
[Mass screening for cancer--where do we stand?]. Tidsskr Nor Laegeforen (1991) 0.75
Overexpression of the epidermal growth factor receptor gene in a human carcinoma cell line, derived from a brain metastasis. J Neurooncol (1989) 0.75
Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines. APMIS (1988) 0.75
Fetal thymus transplantations in severe combined immunodeficiency. Scand J Immunol (1976) 0.75